Critical issues in peripheral arterial disease detection and management: a call to action.

Jill J. F. Belch, MD; Eric J. Topol, MD; Giancarlo Agnelli, MD; Michel Bertrand, MD; Robert M. Califf, MD; Denis L. Clement, MD; Mark A. Creager, MD; J. Donald Easton, MD; James R. Gavin III, MD, PhD; Philip Greenland, MD; Graeme Hankey, MD; Peter Hanrath, MD; Alan T. Hirsch, MD; Jurgen Meyer, MD; Sidney C. Smith, MD; Frank Sullivan, PhD; Michael A. Weber, MD; for the Prevention of Atherothrombotic Disease Network

[1]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.

[2]  E. Barrett-Connor,et al.  TABLE 1 Prevalence of PAD by traditional assessment : intermittent claudication and pulse palpation % Claudication % Pulse abnormalities Rose Femoral Posterior Dorsalis n Rose , 2005 .

[3]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[4]  M. A. van 't Hof,et al.  Decreased Ankle/Brachial Indices in Relation to Morbidity and Mortality in Patients with Peripheral Arterial Disease , 1997, Vascular medicine.

[5]  J. Lekakis,et al.  Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. , 2000, The American journal of cardiology.

[6]  J. Cruickshank.  The case for beta‐blockers as first‐line antihypertensive therapy , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[7]  Arno W. Hoes,et al.  Peripheral arterial disease in the elderly: The Rotterdam Study. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[8]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[9]  W. Aronow.  Treatment of older persons with hypercholesterolemia with and without cardiovascular disease. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  L. Poston,et al.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society , 1999, Journal of Human Hypertension.

[11]  Statin therapy: where are we? Where do we go next? , 2001, The American journal of cardiology.

[12]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[13]  Fiona Fennessy,et al.  Secondary prevention of peripheral vascular disease , 2000, BMJ : British Medical Journal.

[14]  R. Jung,et al.  Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic , 1999 .

[15]  Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section D: chronic critical limb ischaemia. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[16]  J. West.  Cost-Effective Strategies for the Management of Vascular Disease , 1997, Vascular medicine.

[17]  L. Bouter,et al.  Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[19]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[20]  R B D'Agostino,et al.  Intermittent claudication. A risk profile from The Framingham Heart Study. , 1997, Circulation.

[21]  Ames,et al.  PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA , 2000 .

[22]  A. Gardner,et al.  Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. , 1995, JAMA.

[23]  H. G. Beebe.  Intermittent claudication: effective medical management of a common circulatory problem. , 2001, The American journal of cardiology.

[24]  J. Dormandy,et al.  Intermittent claudication: a condition with underrated risks. , 1999, Seminars in vascular surgery.

[25]  Philip D. Harvey,et al.  Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.

[26]  J. Lakier.  Smoking and cardiovascular disease. , 1992, The American journal of medicine.

[27]  R Ferrini,et al.  Screening mammography for breast cancer: American College of Preventive Medicine practice policy statement. , 1996, American journal of preventive medicine.

[28]  C. Athanasoulis,et al.  Preoperative imaging of the carotid bifurcation. Current trends. , 2000, International angiology : a journal of the International Union of Angiology.

[29]  Prospective Diabetes Study Group complications in type 2 diabetes : UKPDS 39 of macrovascular and microvascular Efficacy of atenolol and captopril in reducing risk , 1998 .

[30]  M. Criqui,et al.  The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease , 1998, Vascular medicine.

[31]  J F Potter,et al.  Extract from : , 2009 .

[32]  W. Kannel,et al.  Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: the Framingham Study. , 1993, American heart journal.

[33]  L. Fried,et al.  Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study. , 2000, Circulation.

[34]  R. Prescott,et al.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.

[35]  D. Hunninghake,et al.  The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care. , 2001, Vascular medicine.

[36]  J. Hornaday,et al.  Cancer Facts & Figures 2004 , 2004 .

[37]  F. Fowkes,et al.  The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. , 1992, Journal of clinical epidemiology.

[38]  N. Powe,et al.  Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[39]  Dormandy Ja.  Epidemiology and natural history of arterial diseases of the lower limbs , 1995 .

[40]  A. Adrain,et al.  A comparison of fecal occult-blood tests for colorectal-cancer screening. , 1996, The New England journal of medicine.

[41]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[42]  M. Dennis.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[43]  M. Criqui,et al.  Peripheral arterial disease detection, awareness, and treatment in primary care. , 2001, JAMA.

[44]  A. Algra,et al.  Carotid artery stenosis in patients with peripheral arterial disease: The SMART study , 1999 .

[45]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[46]  R. Sacco,et al.  Supplement to the Guidelines for the Management of Transient Ischemic Attacks A Statement From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association , 1999 .

[47]  F. Mastaglia,et al.  Asymptomatic Carotid Artery Stenosis Associated with Peripheral Vascular Disease: A Prospective Study , 1999 .

[48]  D L Sackett,et al.  Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. , 1996, Circulation.

[49]  W. Krupski,et al.  Antithrombotic therapy in peripheral arterial occlusive disease. , 1998, Chest.

[50]  J. Knottnerus,et al.  Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease: The Limburg PAOD Study , 1998 .

[51]  Evan R. Myers,et al.  Accuracy of the Papanicolaou Test in Screening for and Follow‐up of Cervical Cytologic Abnormalities: A Systematic Review , 2001 .

[52]  P. Wolf,et al.  Antiplatelet therapy in the prevention of ischemic vascular events: Literature review and evidence‐based guidelines for drug selection , 1999, Clinical cardiology.

[53]  E. Barrett-Connor,et al.  The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. , 1985, Circulation.

[54]  J. Tjon,et al.  Treatment of intermittent claudication with pentoxifylline and cilostazol. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[55]  Janet B. Dunbar,et al.  Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. , 1996, International journal of epidemiology.

[56]  J. Santilli,et al.  Chronic critical limb ischemia: diagnosis, treatment and prognosis. , 1999, American family physician.

[57]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[58]  R. Langer,et al.  Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease , 1992 .

[59]  L. Chambless,et al.  Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. , 1997, Atherosclerosis.

[60]  J. Regensteiner,et al.  A patient-derived perspective of health-related quality of life with peripheral arterial disease. , 2002, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.